Relative selenium insufficiency is a risk factor for developing severe Graves’ orbitopathy: a case–control study

BACKGROUND/AIMS: Selenium (Se), an antioxidant agent, is effective in preventing mild Graves’ orbitopathy (GO) deterioration. However, the significant risk of low serum Se concentration for GO progression has not been identified. Here, we aimed to investigate the risk of relative Se insufficiency an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMJ Open Ophthalmol
Autores principales: Lumyongsatien, Mingkwan, Bhaktikamala, Unnkade, Thongtong, Pennung, Sintuwong, Sunisa, Nimitwongsakul, Ornvenus, Kanokkantapong, Jugchawin, Pongpirul, Krit
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2021
Materias:
Orbit and Oculoplastics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8112433/
https://ncbi.nlm.nih.gov/pubmed/34041363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2021-000713
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares